[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355574-105":59,"doc-detail-355574-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","non-coding-rnas-in-cancer-decoding-regulatory-networks-for-liquid-biopsy-applications","Non-Coding RNAs in Cancer - Decoding Regulatory Networks for Liquid Biopsy Applications","","Non-coding RNAs (ncRNAs) act as key regulators of gene expression and cellular homeostasis, and their dysregulation is a cancer hallmark. Diverse ncRNA classes—including microRNAs, long non-coding RNAs, circular RNAs, and other small ncRNAs—form regulatory networks that govern tumor initiation, progression, metastasis, and therapy response via transcriptional, post-transcriptional, epigenetic, and competitive endogenous RNA mechanisms. Many ncRNAs circulate in blood, urine, and saliva as stable, minimally invasive liquid-biopsy biomarkers. This narrative review links ncRNA regulatory circuitry to liquid biopsy applications, emphasizing circulating ncRNAs, multi-class integration, and multi-analyte panels combining ncRNAs with circulating DNA and protein markers. It also outlines technical and clinical barriers to clinical translation and future directions for ncRNA-guided precision oncology.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/non-coding-rnas-in-cancer-decoding-regulatory-networks-for-liquid-biopsy-applications/355574/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/non-coding-rnas-in-cancer-decoding-regulatory-networks-for-liquid-biopsy-applications/355574.png","ImageObject",300,407,{"name":92,"@type":93},"Angel","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which ncRNA types are highlighted in the review?","Question",{"text":112,"@type":113},"The review emphasizes microRNAs, long non-coding RNAs, circular RNAs, and other small ncRNA species that participate in regulatory networks in cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do ncRNAs influence cancer biology?",{"text":117,"@type":113},"ncRNAs shape tumor-related molecular circuitry through transcriptional regulation, post-transcriptional gene silencing, epigenetic modulation, and competitive endogenous RNA interactions.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are circulating ncRNAs important for liquid biopsy?",{"text":121,"@type":113},"Many ncRNAs are released into biofluids and remain stable extracellularly, enabling minimally invasive biomarkers for cancer detection, stratification, and treatment monitoring.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355574,1790198672,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":29,"preview_urls":146},687207412472,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Review  \nNon-Coding RNAs in Cancer: Decoding Regulatory Networks for Liquid Biopsy Applications  \nEvelina Charidemou  and Christos Papaneophytou *  \nAcademic Editor: AmilM. Shah  \nReceived: 17 March 2026  \nRevised: 2 April 2026  \nAccepted: 4 April 2026  \nPublished: 13 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \nDepartment of Life Sciences, School of Life and Health Sciences, University of Nicosia, Nicosia 2417, Cyprus; [charidemou.e@unic.ac.cy](charidemou.e@unic.ac.cy)  \n* [Correspondence: papaneophytou.c@unic.ac.cy](Correspondence: papaneophytou.c@unic.ac.cy); Tel.: +357-22841941  \nAbstract  \nNon-coding RNAs (ncRNAs) have emerged as important regulators of gene expression and cellular homeostasis, and their dysregulation is now recognized as a hallmark of cancer. Over the past decades, extensive research has demonstrated that diverse ncRNA classes, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and other small ncRNA species, participate in complex regulatory networks that influence tumor initiation, progression, metastasis, and therapy response. Through mechanisms such as transcriptional regulation, post-transcriptional gene silencing, epigenetic modulation, and competitive endogenous RNA interactions, ncRNAs shape the molecular circuitry underlying cancer development. In addition to their functional roles in tumor biology, many ncRNAs are released into biological fluids and can be detected as circulating molecules in blood, urine, saliva, and other biofluids. Their remarkable stability in extracellular environments has generated considerable interest in their use as minimally invasive biomarkers in liquid biopsy applications. Emerging evidence has shown that circulating ncRNAs (c-ncRNAs) can support cancer detection, disease stratification, and treatment monitoring. This narrative review provides an integrated view that links ncRNA-mediated regulatory networks with their application as liquid biopsy biomarkers, positioning ncRNAs as comprehensive indicators of tumor conditions. Particular emphasis is placed on c-ncRNA biomarkers, the integration of multiple ncRNA classes, and multi-analyte biomarker strategies that combine ncRNAs with complementary circulating molecules such as cell-free DNA and protein markers. Finally, we discuss the technical and clinical challenges that currently limit the translation of ncRNA-based diagnostics into clinical practice and highlight future directions for advancing ncRNA-guided liquid biopsy approaches in precision oncology.  \nKeywords: non-coding RNAs; circulating ncRNAs; multianalyte liquid biopsy; cancer attractor states; regulatory networks; biomarker panels; cell-free DNA; cancer biomarkers  \n1. Introduction  \nCancer remains one of the biggest challenges to global public health. The Global Burden of Disease (GBD) 2023 study estimated 18.5 million new cancer cases (95% uncertainty interval [UI] 16.4–20.7 million; excluding non-melanoma skin cancer) and 10.4 million cancer-related deaths (95% UI 9.6–10.9 million) in 2023, confirming cancer as the second leading cause of death worldwide [1,2] . Breast cancer was the most commonly diagnosed cancer, followed by cancers of the trachea, bronchus, lung, colorectal cancer (CRC), prostate cancer, and stomach cancer. In contrast, lung cancer remained the leading cause of cancer  \ndeath [1] . Notably, in 2023, 41.7%(95% UI 37.8–45.4%) of cancer deaths were linked to known behavioral and environmental risk factors [1] . The burden is projected to rise significantly, with an estimated 30.5 million (95% UI 22.9–38.9 million) new diagnoses and 18.6 million (95% UI 15.6–21.5 million) deaths expected each year by 2050, representing increases of 60.7% and 74.5%, respectively [1,2] . This remarkable diversity across organ systems, combined wit","cbCaikwy441NEA4g","https://ap.wps.com/l/cbCaikwy441NEA4g","pdf",2642502,53,"English","# Introduction\n## Cancer as a global public health challenge\n## Molecular basis of cancer progression\n## System-level approaches and multi-omics resources","[{\"question\":\"Which ncRNA types are highlighted in the review?\",\"answer\":\"The review emphasizes microRNAs, long non-coding RNAs, circular RNAs, and other small ncRNA species that participate in regulatory networks in cancer.\"},{\"question\":\"How do ncRNAs influence cancer biology?\",\"answer\":\"ncRNAs shape tumor-related molecular circuitry through transcriptional regulation, post-transcriptional gene silencing, epigenetic modulation, and competitive endogenous RNA interactions.\"},{\"question\":\"Why are circulating ncRNAs important for liquid biopsy?\",\"answer\":\"Many ncRNAs are released into biofluids and remain stable extracellularly, enabling minimally invasive biomarkers for cancer detection, stratification, and treatment monitoring.\"}]","Non-Coding RNAs in Cancer - Decoding Regulatory Networks for Liquid Biopsy Applications | PDF",1790119945,134,[147,151,155,159,163,167],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0b66474730dd80b3245bebf929c2f3b8.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c5e2105ab4576a5d109aa05175a5f7a.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f578e02341fa92e92804c70aaf26afcb.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4242e535e618fed867fd110600a20335.webp",980,1385,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/973d04606dde6e4b4e31ba00c878bd21.webp",979,1384,{"page_no":29,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f8217097ef273868ac410a31ce8a7e5.webp",978,1383]